INFORMA MARKETS - ENGINEERING
20.3.2023 09:08:26 CET | ACCESS Newswire | Press release
Members include global automobile and EV leaders such as BMW, Siemens, Mitsubishi and Bloomberg.
STUTTGART, GERMANY / ACCESSWIRE / March 20, 2023 / The Battery Show Europe, the must-attend event connecting the European and international advanced battery and EV/HEV tech community, co-located with The Electric & Hybrid Vehicle Technology Expo Europe, announces registration is now live as expo is set to take place May 23-25 at the Messe Stuttgart in Stuttgart, Germany.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.New this year, The Battery Show Europe will host its first-ever Advisory Board boasting a list of 20 industry leading experts and top-tier notable brands from global organizations such as: PowerCo, Mitsubishi Electric Europe BV, Volta Energy Technologies, Caterpillar Inc., Siemens AG, BMW Group, and BloombergNEF among others. The advisory board serves to educate the EV and battery fields through real-life experiences and tangible solutions across a variety of related verticals.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page."Advanced battery and electric vehicle markets are expected to grow at a tremendous rate with growing consumer investment across various products and technologies. The Battery Show Europe and Electric & Hybrid Vehicle Technology Expo is the international meeting point where EV experts share and discover emerging industry insights and trends," says Rob Shelton, Event Director for The Battery Show Europe. "Our newly appointed Advisory Board, with the support of globally leading organizations, will ensure innovation and market info across sectors is strategically available first to our Battery Show community."
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.The next-generation advanced battery market is expected to reach USD $1,631.95 million by the end of this year (Global Next Generation Advanced Battery Market 2023 Forecast to 2029) and within this, Germany is the European hub for battery manufacturing. The Battery Show Europe is returning to Stuttgart to focus on commercial solutions, knowledge and resources for business application. As Germany is poised to become the second-largest lithium battery producer in the world by 2025, The Battery Show Europe is fast-becoming the critical epicenter to European battery conversations.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Accredited official media partners covering the event will include Batteries International, Cambridge Enertech, Charged, Electric & Hybrid Vehicle Technology and E-mobility Engineering with additional publications in attendance.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.The Battery Show Europe is currently at capacity waitlist for any new additional exhibitors. To register as an attendee or press, please visit www.thebatteryshow.eu.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About Informa Markets - Engineering:
Informa Markets' Engineering portfolio is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa Markets, a subsidiary of Informa plc (LON:INF), the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
Media Contact:
Jordan Douglas
Informa Markets Engineering PR
pr.ime@informa.com
SOURCE: Informa Markets Engineering PR
View source version on accesswire.com:
https://www.accesswire.com/744014/Battery-Show-Europe-Announces-New-2023-International-Advisory-Board
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom